EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation

Abdur Rauf iD, Md Rezaul Islam, Alessandra Gianoncelli iD, Giovanni Ribaudo iD

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70262 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Abdur Rauf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Swabi, Swabi, Anbar, Khyber, Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Pyrophosphatases, Immunotherapy, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Università di Brescia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ectonucleotide pyrophosphatase/phosphodiesterase (ENPP) family regulates critical processes, including nucleotide signaling, bone mineralization, and tumor immune infiltration. Consequently, ENPP1 is recently being re‐discovered as a novel target for immunotherapy in cancer and other diseases. ENPP1 hydrolyzes extracellular nucleotides, modulating calcification and immune responses, and mounting evidence shows that its inhibition through small molecules, including natural compounds, enhances antitumor immunity and metabolic modulation. In this mini‐review, we overview medicinal chemistry strategies, including structure‐based design and nature‐inspired molecules, leading to promising candidates inhibiting ENPP1 with demonstrated preclinical efficacy, alone or in combination therapies. The potential of ENPP1 as a druggable target is explored through a survey of over 70 recent scientific articles. While ENPP1 represents an attractive target in several diseases, limitations are still present: preclinical progresses, challenges in selectivity, and future directions for optimizing lead compounds are discussed within the mini‐review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Diester HydrolasesPyrophosphatasesImmunotherapyEnzyme InhibitorsNeoplasmsAntineoplastic AgentsHumansAnimalsChemistry, PharmaceuticalDrug DesignMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

ENPP1PDEcGAMPmedicinal chemistrynatural compounds

Substanzen

Phosphoric Diester HydrolasesPyrophosphatasesectonucleotide pyrophosphatase phosphodiesterase 1Enzyme InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, University of Swabi, Swabi, Anbar, Khyber, Pakhtunkhwa, Pakistan.
  • Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Daffodil Smart City, Bangladesh.
  • Department of Molecular and Translational Medicine, Università di Brescia, Brescia, Italy.

ORCID-Profile: Abdur Rauf, Alessandra Gianoncelli, Giovanni Ribaudo

Förderung

  • Università di Brescia

Zitieren

APA

Rauf, A., Islam, M. R., Gianoncelli, A., & Ribaudo, G. (2026). Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70262

Vancouver

Rauf A, Islam MR, Gianoncelli A, Ribaudo G. Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70262

BibTeX
@article{Rauf2026,
  author = {Rauf, Abdur and Islam, Md Rezaul and Gianoncelli, Alessandra and Ribaudo, Giovanni},
  title = {Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70262}
}
Kostenlos starten →